Analysis of cell lysates collected at 72 h after treatment showed increased PKR, p38MAPK, and pJNK expression in Ad-mda7-treated ovarian cancer cells but not in PBS-treated or Ad-luc-treated cancer cells (Figure 3). This evidence concerns the gene EIF2AK2 and cancer.